300253.SZ SHZ
Winning Health Technology Group Co., Ltd.
1W: -2.4%
1M: -1.3%
3M: +1.3%
YTD: -38.2%
1Y: -33.3%
3Y: -0.1%
5Y: -57.5%
¥6.98 ($1.04)
+0.02 (+0.29%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$8.8B
+2.4% ▲
5Y CAGR: +11.3%
Total Liabilities
$2.8B
-1.6% ▼
5Y CAGR: +18.4%
Shareholders Equity
$6.0B
+4.8% ▲
5Y CAGR: +9.8%
Cash & Investments
$1.3B
+20.2% ▲
5Y CAGR: +13.4%
Total Debt
$1.1B
+2.6% ▲
5Y CAGR: +37.4%
Net Debt
-$230M
-528.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $989M | $1.6B | $1.3B | $1.1B | $1.3B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $3M |
| Cash & ST Investments | $989M | $1.6B | $1.3B | $1.1B | $1.3B |
| Net Receivables | $1.9B | $2.2B | $2.9B | $3.3B | $3.5B |
| Inventory | $128M | $133M | $98M | $111M | $111M |
| Other Current Assets | $189M | $226M | $2.9B | $285M | $59M |
| Total Current Assets | $3.2B | $4.2B | $4.3B | $4.9B | $5.1B |
| Property, Plant & Equip. | $465M | $541M | $529M | $509M | $493M |
| Goodwill & Intangibles | $1.3B | $1.6B | $1.8B | $2.0B | $2.0B |
| Long-Term Investments | $841M | $1.0B | $990M | $947M | $896M |
| Other Non-Current Assets | $119K | $13M | $16M | $34M | $31M |
| Total Non-Current Assets | $2.8B | $3.3B | $3.5B | $3.7B | $3.7B |
| Total Assets | $6.1B | $7.5B | $7.8B | $8.5B | $8.8B |
| — Liabilities — | |||||
| Accounts Payable | $394M | $499M | $603M | $675M | $698M |
| Short-Term Debt | $214M | $0 | $47M | $58M | $40M |
| Deferred Revenue | $606M | $725M | $194M | $0 | $0 |
| Other Current Liabilities | $15M | $50M | $738M | $911M | $211M |
| Total Current Liabilities | $1.2B | $1.3B | $1.6B | $1.7B | $1.6B |
| Long-Term Debt | $0 | $898M | $950M | $1.0B | $1.1B |
| Other Non-Current Liab. | $23M | $53M | $136M | $100M | $71M |
| Total Non-Current Liabilities | $114M | $1.0B | $1.1B | $1.2B | $1.2B |
| Total Liabilities | $1.3B | $2.3B | $2.7B | $2.9B | $2.8B |
| — Equity — | |||||
| Common Stock | $2.1B | $2.1B | $2.1B | $2.2B | $2.2B |
| Retained Earnings | $1.8B | $2.1B | $2.1B | $2.4B | $2.5B |
| Accumulated OCI | $350M | $464M | $588M | $801M | $606M |
| Total Stockholders Equity | $4.5B | $5.1B | $5.1B | $5.7B | $6.0B |
| Total Liabilities & Equity | $6.1B | $7.5B | $7.8B | $8.5B | $8.8B |
| — Key Metrics — | |||||
| Total Debt | $215M | $949M | $1.1B | $1.1B | $1.1B |
| Net Debt | -$774M | -$652M | -$215M | -$37M | -$230M |
| Total Investments | $841M | $1.0B | $990M | $947M | $899M |